Evidence map›Paper›PMID 38674582›Full record

ArticleMicroorganisms2024

Akbar Hussain, Binqi Rui, Hayan Ullah, Panpan Dai, Kabir Ahmad, Jieli Yuan, Yinhui Liu, Ming Li

Open access · goldAbstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Isolation and Mechanistic Characterization ofFoods (Basel, Switzerland) · 2026
    Article
  6. Article
  7. Review
  8. Review
  9. The Gut Microbiome in Hyperuricemia and Gout.Arthritis & rheumatology (Hoboken, N.J.) · 2025
    Review
  10. Article
  11. Review
  12. Article
  13. Frontiers in nutrition · 2025
    Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Frontiers in nutrition · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Akbar HussainCollege of Basic Medical Science, Dalian Medical University, Dalian 116041, China.
Binqi RuiCollege of Basic Medical Science, Dalian Medical University, Dalian 116041, China.
Hayan UllahCollege of Basic Medical Science, Dalian Medical University, Dalian 116041, China.
Panpan DaiCollege of Basic Medical Science, Dalian Medical University, Dalian 116041, China.
Kabir AhmadDepartment of Physiology, Dalian Medical University, Dalian 116041, China.
Jieli YuanCollege of Basic Medical Science, Dalian Medical University, Dalian 116041, China.
Yinhui LiuCollege of Basic Medical Science, Dalian Medical University, Dalian 116041, China.ORCID 0000-0001-8985-6769
Ming LiCollege of Basic Medical Science, Dalian Medical University, Dalian 116041, China.
Dalian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperuricemia is a prevalent metabolic disorder that arises from abnormal purine metabolism and reduced excretion of uric acid (UA). The gut microbiota plays a significant role in the biosynthesis and excretion of UA. Probiotics capable of purine degradation possess the potential to prevent hyperuricemia. Our study aimed to screen probiotics in areas with abundant dairy products and longevity populations in China, which could attenuate the level of UA and explore the underlying mechanism. In this study, twenty-three lactic acid bacteria isolated from healthy Chinese infant feces and traditional fermented foods such as hurood and lump milk were evaluated for the ability to tolerance acid, bile, artificial gastric juice, and artificial intestinal juice to determine the potential of the candidate strains as probiotics. Eight strains were identified as possessing superior tolerance to simulated intestinal conditions and were further analyzed by high-performance liquid chromatography (HPLC), revealing that

Indexed as

gut microbiotahyperuricemiainflammationprobiotictranscriptomeuric acid transporter

Identifiers

PMID38674582
PMCPMC11052267
OpenAlexW4393081361

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.